M. Alonso

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

H. Rugo, M. Gnant, H. Iwata, 2020, Clinical breast cancer.

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

D. Smith, Y. Wang, J. Wang, 2012, British Journal of Cancer.

Phase II study of sagopilone (ZK-EPO) plus prednisone as first-line chemotherapy in patients with metastatic androgen-independent prostate cancer (AIPC)

D. Smith, T. Beer, G. Jones, 2008 .

Phase II study of first-line sagopilone combined with prednisone in patients with metastatic castration-resistant prostate cancer (CRPC).

D. Smith, Y. Wang, J. Wang, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.